Lung cancer in never smokers — a different disease

[1]  P. Wild,et al.  Lung cancer and exposure to metals: the epidemiological evidence. , 2009, Methods in molecular biology.

[2]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[3]  J. Herman,et al.  Arsenic in drinking water and lung cancer: a systematic review. , 2008, Environmental research.

[4]  Erika Avila-Tang,et al.  Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies , 2008, PLoS medicine.

[5]  Ya‐Wen Cheng,et al.  Association of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation with p53 Mutation Occurrence in Non-Small Cell Lung Cancer with Different Histology, Gender, and Smoking Status , 2008, Annals of Surgical Oncology.

[6]  J. Minna,et al.  Prevalence and specificity of LKB1 genetic alterations in lung cancers , 2007, Oncogene.

[7]  Luc Girard,et al.  Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. , 2007, Cancer research.

[8]  Y. Yatabe,et al.  Epidermal growth factor receptor mutations in lung cancers , 2007, Pathology international.

[9]  Ziding Feng,et al.  Memorial Sloan-Kettering Cancer , 2006 .

[10]  J. Siemiatycki,et al.  Risk of lung cancer from residential heating and cooking fuels in Montreal, Canada. , 2007, American journal of epidemiology.

[11]  Daniel A. Haber,et al.  Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.

[12]  N. Girard,et al.  Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. , 2007, Veterinary research.

[13]  A. Gazdar.  DNA repair and survival in lung cancer--the two faces of Janus. , 2007, The New England journal of medicine.

[14]  Janakiraman Subramanian,et al.  Lung cancer in never smokers: a review. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Thun,et al.  Lung cancer, smoke exposure, and sex. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  L. Holmberg,et al.  Lung cancer incidence in never smokers. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Fishbein,et al.  Estrogen receptor signaling pathways in human non-small cell lung cancer , 2007, Steroids.

[18]  K. Straif,et al.  Lung cancer risk and workplace exposure to environmental tobacco smoke. , 2007, American journal of public health.

[19]  K. Matsuo,et al.  Risk factors differ for non‐small‐cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case‐control study in Japanese , 2007, Cancer science.

[20]  Jeffrey A Whitsett,et al.  Transcriptional control of lung morphogenesis. , 2007, Physiological reviews.

[21]  P. Brennan,et al.  High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. , 2006, American journal of epidemiology.

[22]  R. Cerfolio,et al.  Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. , 2006, Chest.

[23]  E. Cavalieri,et al.  Catechol Quinones of Estrogens in the Initiation of Breast, Prostate, and Other Human Cancers , 2006, Annals of the New York Academy of Sciences.

[24]  J. Minna,et al.  Establishment and Expression Profiling of New Lung Cancer Cell Lines from Chinese Smokers and Lifetime Never-Smokers , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  P. Laurent-Puig,et al.  Epidermal Growth Factor Receptor Mutation in Lung Cancer are Linked to Bronchioloalveolar Differentiation , 2006, The American journal of surgical pathology.

[26]  Nigel Gray,et al.  The consequences of the unregulated cigarette , 2006, Tobacco Control.

[27]  P. Boffetta.  Human cancer from environmental pollutants: the epidemiological evidence. , 2006, Mutation research.

[28]  E. Gabrielson.  Worldwide trends in lung cancer pathology , 2006, Respirology.

[29]  Yu Zhao,et al.  Air pollution and lung cancer risks in China--a meta-analysis. , 2006, The Science of the total environment.

[30]  J Jack Lee,et al.  Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer , 2006, Cancer.

[31]  H. Varmus,et al.  Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. , 2006, Genes & development.

[32]  H. Koong,et al.  Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Michael J Thun,et al.  Lung cancer death rates in lifelong nonsmokers. , 2006, Journal of the National Cancer Institute.

[34]  Ya‐Wen Cheng,et al.  Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. , 2006, Japanese journal of clinical oncology.

[35]  J. Siegfried,et al.  Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond. , 2006, The Lancet. Oncology.

[36]  I. Yu,et al.  Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. , 2006, Cancer research.

[37]  M. Inoue,et al.  Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. , 2006, Japanese journal of clinical oncology.

[38]  R. Wilson,et al.  Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Takayuki Kosaka,et al.  Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  S. Mahmood,et al.  Characteristics of lung cancer patients--the Shaukat Khanum Memorial experience. , 2006, Asian Pacific journal of cancer prevention : APJCP.

[41]  E. G. Letourneau,et al.  A Combined Analysis of North American Case-Control Studies of Residential Radon and Lung Cancer , 2006, Journal of toxicology and environmental health. Part A.

[42]  T. Oyama,et al.  Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking , 2006, British Journal of Cancer.

[43]  J. Minna,et al.  Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features , 2006, Clinical Cancer Research.

[44]  S. Toyooka,et al.  Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. , 2006, Cancer research.

[45]  I. Wistuba,et al.  Lung cancer preneoplasia. , 2006, Annual review of pathology.

[46]  A. Gazdar,et al.  Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers , 2006, International journal of cancer.

[47]  N. Hanna.  The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer: A Retrospective AnalysisToh C-K, Wong E-H, Lim W-T, et al (Natl Cancer Ctr, Singapore Chest 126:1750-1756, 2004§ , 2006 .

[48]  A. Potti,et al.  Hormone replacement therapy is associated with decreased survival in women with lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  G. Pfeifer.  Mutagenesis at methylated CpG sequences. , 2006, Current topics in microbiology and immunology.

[50]  M. Inoue,et al.  Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. , 2006, Japanese journal of clinical oncology.

[51]  J. Minna,et al.  Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.

[52]  Xifeng Wu,et al.  Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. , 2005, Mutation research.

[53]  P. Validire,et al.  Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[54]  M. Inoue,et al.  Reproductive factors, hormone use and the risk of lung cancer among middle‐aged never‐smoking Japanese women: A large‐scale population‐based cohort study , 2005, International journal of cancer.

[55]  S. Ou,et al.  bronchioloalveolar carcinoma : Improvement in survival after release of the 1999 WHO classification of lung tumors , 2006 .

[56]  P. Brennan,et al.  Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. , 2005, American journal of epidemiology.

[57]  Kevin Carroll,et al.  Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) , 2005, The Lancet.

[58]  H. Pass,et al.  Nuclear Estrogen Receptor β in Lung Cancer: Expression and Survival Differences by Sex , 2005, Clinical Cancer Research.

[59]  Yih-Leong Chang,et al.  The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. , 2005, The Journal of thoracic and cardiovascular surgery.

[60]  T. Eisen,et al.  Systematic review of the relationship between family history and lung cancer risk , 2005, British Journal of Cancer.

[61]  Xin Li,et al.  TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  J. Minna,et al.  EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. , 2005, Cancer research.

[63]  M. Ostland,et al.  Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  Tony Fletcher,et al.  Lung cancer and indoor pollution from heating and cooking with solid fuels: the IARC international multicentre case-control study in Eastern/Central Europe and the United Kingdom. , 2005, American journal of epidemiology.

[65]  Hideki Kawai,et al.  Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[66]  Renato Martins,et al.  Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.

[67]  S. Kardia,et al.  Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. , 2005, JAMA.

[68]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[69]  P. Hainaut,et al.  TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. , 2005, Cancer research.

[70]  E. Tan,et al.  Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients , 2005, British Journal of Cancer.

[71]  W. Akerley,et al.  Natual history of non-small cell lung cancer in non-smokers , 2005 .

[72]  D. Christiani,et al.  Molecular epidemiology of non-small cell lung cancer. , 2005, Seminars in respiratory and critical care medicine.

[73]  Anthony J Alberg,et al.  Epidemiology of lung cancer: looking to the future. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  Y. Yatabe,et al.  EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma , 2005, The American journal of surgical pathology.

[75]  M. Fishbein,et al.  Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells , 2005, Steroids.

[76]  Jolanta Lissowska,et al.  Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. , 2005, Journal of the National Cancer Institute.

[77]  F. Gilliland,et al.  Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers , 2005, International journal of cancer.

[78]  W. Park,et al.  Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas , 2005, Virchows Archiv.

[79]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[80]  A. Jemal,et al.  Contemporary Lung Cancer Trends among U.S. Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[81]  J. Siegfried,et al.  Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. , 2005, Cancer research.

[82]  J. Siegfried,et al.  Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. , 2005, Cancer research.

[83]  A. Marchetti,et al.  EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  H. Varmus,et al.  KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.

[85]  M Paesmans,et al.  The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis , 2004, British Journal of Cancer.

[86]  C. Harris,et al.  p53: traffic cop at the crossroads of DNA repair and recombination , 2005, Nature Reviews Molecular Cell Biology.

[87]  R Doll,et al.  Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies , 2004, BMJ : British Medical Journal.

[88]  Takayuki Kosaka,et al.  Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer , 2004, Cancer Research.

[89]  E. Tan,et al.  The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. , 2004, Chest.

[90]  Richa Gupta,et al.  Clinicopathological study of bronchogenic carcinoma , 2004, Respirology.

[91]  K. Reynolds,et al.  Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. , 2004, American journal of public health.

[92]  M. Chan-yeung,et al.  Lung cancer epidemiology and risk factors in Asia and Africa. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[93]  Marshall W. Anderson,et al.  A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.

[94]  G. Bepler,et al.  Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. , 2004, Chest.

[95]  Ping Yang,et al.  Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. , 2004, The Annals of thoracic surgery.

[96]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[97]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[98]  William Pao,et al.  Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[99]  J Smith,et al.  Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.

[100]  M. Goldberg,et al.  A case–control study of lung cancer and environmental tobacco smoke among nonsmoking women living in Shanghai, China , 1999, Cancer Causes & Control.

[101]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[102]  F. Bray,et al.  Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. , 2004, European journal of cancer.

[103]  P. Kvale,et al.  Smoking and lung cancer survival: the role of comorbidity and treatment. , 2004, Chest.

[104]  Fredrik Nyberg,et al.  Contribution of environmental factors to cancer risk. , 2003, British medical bulletin.

[105]  R. Field,et al.  Occupation and Lung Cancer in Non-Smokers , 2003, Reviews on environmental health.

[106]  L. Le Marchand,et al.  CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. , 2003, Carcinogenesis.

[107]  D. Christiani,et al.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[108]  H. Wichmann,et al.  Hormonal factors and risk of lung cancer among women? , 2003, International journal of epidemiology.

[109]  Toshihide Tsuda,et al.  The TP53 gene, tobacco exposure, and lung cancer , 2003, Human mutation.

[110]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[111]  S. Shapiro,et al.  Estrogen replacement therapy and risk of lung cancer , 2002, Pharmacoepidemiology and drug safety.

[112]  P. Shields.  Molecular epidemiology of smoking and lung cancer , 2002, Oncogene.

[113]  P Boffetta,et al.  Tobacco use and cancer causation: association by tumour type , 2002, Journal of internal medicine.

[114]  A. Haugen,et al.  Expression of estrogen receptors α and β in human lung tissue and cell lines , 2002 .

[115]  Stephen S Hecht,et al.  Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. , 2002, The Lancet. Oncology.

[116]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[117]  B. Stripp,et al.  Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. , 2002, The American journal of pathology.

[118]  K. Roszkowski,et al.  Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[119]  Q. Lan,et al.  Household stove improvement and risk of lung cancer in Xuanwei, China. , 2002, Journal of the National Cancer Institute.

[120]  Y. Yatabe,et al.  TTF-1 Expression in Pulmonary Adenocarcinomas , 2002, The American journal of surgical pathology.

[121]  J. Lubin,et al.  Lung Cancer and Indoor Exposure to Coal and Biomass in Rural China , 2002, Journal of occupational and environmental medicine.

[122]  G. Hillerdal,et al.  A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits. , 2002, Lung cancer.

[123]  J. Luketich,et al.  Human Non-Small Cell Lung Tumors and Cells Derived from Normal Lung Express Both Estrogen Receptor α and β and Show Biological Responses to Estrogen , 2002 .

[124]  S. Spivack,et al.  Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue , 2002, Molecular and Cellular Endocrinology.

[125]  J. Rachtan.  Smoking, passive smoking and lung cancer cell types among women in Poland. , 2002, Lung cancer.

[126]  Jay H Lubin,et al.  Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. , 2002, Lung cancer.

[127]  A. Haugen,et al.  Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. , 2002, Lung cancer.

[128]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[129]  W. Travis,et al.  The new World Health Organization classification of lung tumours , 2001, European Respiratory Journal.

[130]  P. Brennan,et al.  Incidence of lung cancer in a large cohort of non‐smoking men from Sweden , 2001, International journal of cancer.

[131]  M. Olivier,et al.  TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. , 2001, Mutagenesis.

[132]  S D Stellman,et al.  Smoking and lung cancer risk in American and Japanese men: an international case-control study. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[133]  D. Sidransky,et al.  Cigarette smoking is strongly associated with mutation of the K‐ras gene in patients with primary adenocarcinoma of the lung , 2001, Cancer.

[134]  J. Siegfried,et al.  Women and lung cancer: does oestrogen play a role? , 2001, The Lancet. Oncology.

[135]  R. Wallace,et al.  Clearing the smoke: the science base for tobacco harm reduction--executive summary. , 2001, Tobacco control.

[136]  C. Harris,et al.  p53 and K-ras mutations in lung cancers from former and never-smoking women. , 2001, Cancer research.

[137]  T. Jacks,et al.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.

[138]  G. Sheu,et al.  The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. , 2001, Cancer research.

[139]  S. Khuder,et al.  Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. , 2001, Lung cancer.

[140]  A. Jemal,et al.  Recent trends in lung cancer mortality in the United States. , 2001, Journal of the National Cancer Institute.

[141]  R. Wallace,et al.  Clearing the Smoke , 2001 .

[142]  R. Wallace,et al.  Clearing the smoke: assessing the science base for tobacco harm reduction. , 2001 .

[143]  J. M. Wu,et al.  Indoor air pollution and pulmonary adenocarcinoma among females: a case-control study in Shenyang, China. , 2000, Oncology Report.

[144]  P Eng,et al.  Fumes from meat cooking and lung cancer risk in Chinese women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[145]  Wang,et al.  Lung cancer and indoor air pollution in rural china. , 2000, Annals of epidemiology.

[146]  Y. Koh,et al.  Characteristics of lung cancer in Korea, 1997. , 2000, Lung cancer.

[147]  H. Lee,et al.  Identification of benzo[a]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions. , 2000, Chemical research in toxicology.

[148]  I. Robbé,et al.  Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China. , 2000, Epidemiology.

[149]  M. Spitz,et al.  Adenocarcinoma of the lung in young patients , 2000, Cancer.

[150]  Y. Ko,et al.  Chinese food cooking and lung cancer in women nonsmokers. , 2000, American journal of epidemiology.

[151]  H. Hausen.  Papillomaviruses in human cancers. , 1999 .

[152]  M. Gerken,et al.  Histologic types of lung carcinoma and age at onset , 1999, Cancer.

[153]  H. zur Hausen.  Papillomaviruses in human cancers. , 1999, Proceedings of the Association of American Physicians.

[154]  P. Shields,et al.  Molecular epidemiology of lung cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[155]  W. Ahrens,et al.  Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. , 1998, Journal of the National Cancer Institute.

[156]  G. Gürsel,et al.  Hospital based survey of lung cancer in Turkey, a developing country, where smoking is highly prevalent. , 1998, Lung cancer.

[157]  A. Marchetti,et al.  Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus. , 1998, British Journal of Cancer.

[158]  R. Brownson,et al.  Epidemiology and prevention of lung cancer in nonsmokers. , 1998, Epidemiologic reviews.

[159]  Chih-Yi Chen,et al.  Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome , 1998, Journal of Cancer Research and Clinical Oncology.

[160]  C. H. Lee,et al.  Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan. , 1997, Mutation research.

[161]  R. Goldbohm,et al.  Occupational exposure to carcinogens and risk of lung cancer: results from The Netherlands cohort study. , 1997, Occupational and environmental medicine.

[162]  A. Marchetti,et al.  Association between cigarette smoking and FHIT gene alterations in lung cancer. , 1997, Cancer research.

[163]  M. Tang,et al.  Cytosine methylation determines hot spots of DNA damage in the human P53 gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[164]  Y. Ko,et al.  Risk factors for primary lung cancer among non-smoking women in Taiwan. , 1997, International journal of epidemiology.

[165]  S. Chiang,et al.  The variation of cell type distribution in lung cancer: a study of 10,910 cases at a medical center in Taiwan between 1970 and 1993. , 1996, Japanese journal of clinical oncology.

[166]  Baosen Zhou,et al.  Lung cancer in nonsmoking Chinese women: a case-control study. , 1996, Lung cancer.

[167]  Y Z Chen,et al.  An epidemiological study of risk factors for lung cancer in Guangzhou, China. , 1996, Lung cancer.

[168]  Yager Jd,et al.  Molecular Mechanisms of Estrogen Carcinogenesis , 1996 .

[169]  J. Yager,et al.  Molecular mechanisms of estrogen carcinogenesis. , 1996, Annual review of pharmacology and toxicology.

[170]  C. Harris,et al.  Mutagens from heated Chinese and U.S. cooking oils. , 1995, Journal of the National Cancer Institute.

[171]  E. Wynder,et al.  Lung cancer pathology in smokers, ex-smokers and never smokers. , 1995, Cancer letters.

[172]  P. Zimmerman,et al.  Human papollomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction , 1994, Cancer.

[173]  F. T. Cross.  Invited commentary: residential radon risks from the perspective of experimental animal studies. , 1994, American journal of epidemiology.

[174]  E. Wynder,et al.  Re: Endocrine factors and adenocarcinoma of the lung in women. , 1994, Journal of the National Cancer Institute.

[175]  M S Li Shuguang,et al.  Analysis of polycyclic aromatic hydrocarbons in cooking oil fumes. , 1994 .

[176]  S. Li,et al.  Analysis of polycyclic aromatic hydrocarbons in cooking oil fumes. , 1994, Archives of environmental health.

[177]  G. Lyman,et al.  Environmental tobacco smoke and lung cancer risk in nonsmoking women. , 1992, Journal of the National Cancer Institute.

[178]  M. Lung,et al.  Incidence of ras oncogene activation in lung carcinomas in Hong Kong , 1992, Cancer.

[179]  W. Blot,et al.  Lung cancer among women in north-east China. , 1990, British Journal of Cancer.

[180]  S. Nesnow,et al.  Mouse skin tumorigenicity studies of indoor coal and wood combustion emissions from homes of residents in Xuan Wei, China with high lung cancer mortality. , 1990, Carcinogenesis.

[181]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .

[182]  J H Ho,et al.  Worldwide epidemiological patterns of lung cancer in nonsmokers. , 1990, International journal of epidemiology.

[183]  B. Henderson,et al.  Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. , 1989, Journal of the National Cancer Institute.

[184]  Malcolm C. Pike,et al.  Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. , 1988, Cancer research.

[185]  J. Fraumeni,et al.  Lung cancer among Chinese women , 1987, International journal of cancer.

[186]  J. Chuang,et al.  Lung cancer and indoor air pollution in Xuan Wei, China. , 1987, Science.

[187]  N. Lee,et al.  An analysis of some risk factors for lung cancer in Hong Kong , 1985, International journal of cancer.

[188]  H. Shimizu,et al.  Comparison of clinico-epidemiological features of lung cancer patients with and without a history of smoking. , 1984, Japanese journal of clinical oncology.

[189]  E. Wynder,et al.  Lung cancer in nonsmokers , 1984, Cancer.

[190]  R. Dhand,et al.  Bronchogenic carcinoma in Northern India. , 1982, Thorax.